5.85
-0.15 (-2.50%)
| Penutupan Terdahulu | 6.00 |
| Buka | 5.96 |
| Jumlah Dagangan | 167,470 |
| Purata Dagangan (3B) | 141,620 |
| Modal Pasaran | 77,551,992 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.78 |
| Harga / Jualan (P/S) | 72.84 |
| Harga / Buku (P/B) | 3.68 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2025 |
| Margin Keuntungan | -42.99% |
| Margin Operasi (TTM) | -76,248.27% |
| EPS Cair (TTM) | -2.87 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -99.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 60.30% |
| Nisbah Semasa (MRQ) | 6.62 |
| Aliran Tunai Operasi (OCF TTM) | -58.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 6.86 M |
| Pulangan Atas Aset (ROA TTM) | -17.83% |
| Pulangan Atas Ekuiti (ROE TTM) | -50.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Precision BioSciences, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.38 |
|
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.94% |
| % Dimiliki oleh Institusi | 42.73% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Aquilo Capital Management, Llc | 31 Mar 2025 | 726,149 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |